tradingkey.logo
tradingkey.logo
Search

AVITA Medical Inc

RCEL
Add to Watchlist
4.630USD
-0.120-2.53%
Close 07-28 16:00ETQuotes delayed by 15 min
712.48MMarket Cap
LossP/E TTM

RCEL Income Statement

You can find the annual or quarterly income statement of AVITA Medical Inc here for insights into the performance and operational efficiency of AVITA Medical Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Total revenue
3.98%19.25M
-4.30%17.61M
-12.71%17.06M
21.21%18.42M
66.73%18.51M
29.67%18.41M
43.25%19.55M
29.29%15.20M
5.25%11.10M
50.13%14.20M
50.08%13.64M
41.01%11.75M
39.94%10.55M
-8.24%9.46M
3.73%9.09M
63.34%8.34M
48.99%7.54M
--10.30M
--8.77M
--5.10M
--5.06M
Revenue
3.98%19.25M
-4.30%17.61M
-12.71%17.06M
21.21%18.42M
66.73%18.51M
29.67%18.41M
43.25%19.55M
29.29%15.20M
5.25%11.10M
50.13%14.20M
50.08%13.64M
41.01%11.75M
39.94%10.55M
-8.24%9.46M
3.73%9.09M
63.34%8.34M
48.99%7.54M
--10.30M
--8.77M
--5.10M
--5.06M
Cost of revenue
37.54%3.47M
44.89%3.19M
0.60%3.04M
-11657.70%-226.53M
76.22%2.52M
27.67%2.20M
48.47%3.02M
-10.99%1.96M
-10.63%1.43M
37.26%1.72M
44.63%2.03M
66.19%2.20M
-4.82%1.60M
-42.62%1.26M
-26.17%1.41M
63.78%1.32M
89.73%1.68M
--2.19M
--1.90M
--809.00K
--886.00K
Operating expenses
-6.76%28.00M
-3.80%27.31M
-21.45%26.06M
-754.01%-200.43M
6.38%30.03M
7.56%28.39M
45.79%33.18M
33.77%30.65M
38.54%28.23M
72.81%26.39M
55.53%22.76M
56.96%22.91M
20.61%20.37M
0.85%15.27M
0.83%14.63M
36.13%14.60M
10.91%16.89M
--15.14M
--14.51M
--10.72M
--15.23M
R&D expenses
-10.42%5.63M
17.34%5.69M
-30.95%3.75M
4.71%5.12M
20.99%6.28M
-28.31%4.85M
23.53%5.43M
-3.72%4.89M
13.26%5.19M
100.21%6.76M
15.66%4.39M
65.94%5.08M
26.69%4.59M
-14.97%3.38M
-7.54%3.80M
-8.99%3.06M
12.98%3.62M
--3.97M
--4.11M
--3.36M
--3.20M
Depreciation, depletion, and amortization
20.35%627.00K
71.15%700.00K
84.57%574.00K
170.59%552.00K
156.65%521.00K
118.72%409.00K
88.48%311.00K
39.73%204.00K
50.37%203.00K
43.85%187.00K
19.57%165.00K
6.57%146.00K
-17.18%135.00K
-25.71%130.00K
-17.37%138.00K
-15.43%137.00K
-22.75%163.00K
--175.00K
--167.00K
--162.00K
--211.00K
Other operating expenses
----
----
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
94.25%-59.00K
76.55%-212.00K
3.81%-530.00K
14.58%-627.00K
-133.18%-1.03M
-58.60%-904.00K
-22.72%-551.00K
-23.15%-734.00K
---440.00K
---570.00K
---449.00K
---596.00K
Operating profit
24.04%-8.75M
2.88%-9.69M
33.98%-9.00M
1516.33%218.85M
32.76%-11.51M
18.18%-9.98M
-49.60%-13.63M
-38.50%-15.45M
-74.30%-17.12M
-109.68%-12.20M
-64.46%-9.11M
-78.20%-11.16M
-5.04%-9.82M
-20.19%-5.82M
3.60%-5.54M
-11.43%-6.26M
8.04%-9.35M
---4.84M
---5.75M
---5.62M
---10.17M
Net non-operating interest income (expenses)
Non-operating interest expense
15.49%1.42M
-3.70%1.25M
-6.70%1.27M
-7.05%1.25M
-9.07%1.23M
15.69%1.30M
13490.00%1.36M
19142.86%1.35M
33800.00%1.36M
18600.00%1.12M
66.67%10.00K
75.00%7.00K
--4.00K
-33.33%6.00K
100.00%6.00K
33.33%4.00K
-100.00%0.00
--9.00K
--3.00K
--3.00K
--7.00K
Gains from sale of securities
----
----
----
----
----
----
----
----
----
----
65.85%-28.00K
85.00%-6.00K
45.95%-20.00K
----
---82.00K
---40.00K
---37.00K
----
----
----
----
Special income (expenses)
81.79%-57.00K
-45.57%-115.00K
12.14%-152.00K
-133620.93%-230.00M
-277.11%-313.00K
-3.95%-79.00K
-4.85%-173.00K
-8500.00%-172.00K
-23.88%-83.00K
16.48%-76.00K
-32.00%-165.00K
96.72%-2.00K
30.93%-67.00K
-166.91%-91.00K
48.56%-125.00K
-408.33%-61.00K
-125.58%-97.00K
--136.00K
---243.00K
---12.00K
---43.00K
- Gains from disposal of fixed assets
----
-688.24%-600.00K
----
----
----
--102.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
50.06%-395.00K
106.35%20.00K
-157.58%-2.75M
54.19%2.48M
-1098.48%-791.00K
-104.97%-315.00K
-273.66%-1.07M
101.12%1.61M
-109.10%-66.00K
984.10%6.34M
261.76%615.00K
634.86%801.00K
2489.29%725.00K
29150.00%585.00K
2328.57%170.00K
2625.00%109.00K
600.00%28.00K
--2.00K
--7.00K
--4.00K
--4.00K
Income before tax
23.31%-10.62M
-0.59%-11.64M
18.86%-13.17M
35.44%-9.92M
25.64%-13.85M
-64.04%-11.57M
-86.56%-16.23M
-48.11%-15.36M
-102.70%-18.63M
-32.35%-7.05M
-55.82%-8.70M
-65.75%-10.37M
2.84%-9.19M
-13.12%-5.33M
6.73%-5.58M
-11.14%-6.26M
7.42%-9.46M
---4.71M
---5.99M
---5.63M
---10.22M
Income tax
-237.50%-11.00K
-189.47%-17.00K
153.57%15.00K
-87.88%4.00K
-73.33%8.00K
58.33%19.00K
-354.55%-28.00K
153.85%33.00K
0.00%30.00K
-50.00%12.00K
175.00%11.00K
225.00%13.00K
650.00%30.00K
242.86%24.00K
-60.00%4.00K
-63.64%4.00K
-60.00%4.00K
--7.00K
--10.00K
--11.00K
--10.00K
Income after tax
23.44%-10.61M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-64.03%-11.59M
-86.01%-16.20M
-48.24%-15.39M
-102.36%-18.66M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-13.46%-5.35M
6.82%-5.59M
-10.99%-6.26M
7.47%-9.46M
---4.72M
---6.00M
---5.64M
---10.23M
Net income from continuous operations
23.44%-10.61M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-64.03%-11.59M
-86.01%-16.20M
-48.24%-15.39M
-102.36%-18.66M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-13.46%-5.35M
6.82%-5.59M
-10.99%-6.26M
7.47%-9.46M
---4.72M
---6.00M
---5.64M
---10.23M
Net income attributable to controlling interests
23.44%-10.61M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-64.03%-11.59M
-86.01%-16.20M
-48.24%-15.39M
-102.36%-18.66M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-13.46%-5.35M
6.82%-5.59M
-10.99%-6.26M
7.47%-9.46M
---4.72M
---6.00M
---5.64M
---10.23M
Net income attributable to common shareholders
23.44%-10.61M
-0.28%-11.62M
18.62%-13.19M
35.56%-9.92M
25.72%-13.86M
-64.03%-11.59M
-86.01%-16.20M
-48.24%-15.39M
-102.36%-18.66M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-13.46%-5.35M
6.82%-5.59M
-10.99%-6.26M
7.47%-9.46M
---4.72M
---6.00M
---5.64M
---10.23M
Basic earnings per share
34.18%-0.35
13.76%-0.38
25.53%-0.46
37.04%-0.38
27.46%-0.53
-59.84%-0.44
-81.84%-0.62
-45.24%-0.60
-98.93%-0.73
-29.93%-0.28
-53.48%-0.34
-64.08%-0.41
3.59%-0.37
-12.42%-0.21
15.29%-0.22
3.89%-0.25
20.21%-0.38
---0.19
---0.26
---0.26
---0.48
Diluted earnings per share
34.18%-0.35
13.76%-0.38
25.53%-0.46
37.04%-0.38
27.46%-0.53
-59.84%-0.44
-81.84%-0.62
-45.24%-0.60
-98.93%-0.73
-29.93%-0.28
-53.48%-0.34
-64.08%-0.41
3.59%-0.37
-12.42%-0.21
15.29%-0.22
3.89%-0.25
20.21%-0.38
---0.19
---0.26
---0.26
---0.48
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read AVITA Medical Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing RCEL stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was AVITA Medical Inc's revenue at year end?

AVITA Medical Inc reported 71.61M in revenue for fiscal year 2025, up from 64.25M in the previous year.

How much revenue did AVITA Medical Inc report in the most recent quarter?

AVITA Medical Inc reported 19.25M in revenue for the most recent quarter, an increase of 3.98% year over year.

What was AVITA Medical Inc's net income for the year?

AVITA Medical Inc posted -48.59M in net income for fiscal year 2025.

How much net income did AVITA Medical Inc post in the last quarter?

AVITA Medical Inc reported -10.61M in net income for the latest quarter。

What was AVITA Medical Inc's annual operating profit?

AVITA Medical Inc's operating income was -41.12M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.